influenza B virus

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:activities gptkb:battle
gptkbp:belongs_to gptkb:Orthomyxoviridae
gptkbp:caused_by gptkb:virus
gptkbp:community_impact millions infected annually
thousands of deaths annually
gptkbp:complications gptkb:healthcare_organization
sinusitis
bronchitis
worsening of chronic conditions
gptkbp:difficulty moderate
gptkbp:duration 5 to 7 days
gptkbp:genetic_diversity high
gptkbp:healthcare gptkb:battle
gptkbp:hosts gptkb:bird
gptkb:Person
pigs
https://www.w3.org/2000/01/rdf-schema#label influenza B virus
gptkbp:is_monitored_by gptkb:CDC
gptkb:WHO
gptkbp:is_protected_by vaccination
gptkbp:is_recognized_by 1940s
gptkbp:is_tested_for serology
viral culture
gptkbp:is_vulnerable_to variable
inactivated
live attenuated
depends on strain match
gptkbp:population_trend pandemic potential low
seasonal epidemics
gptkbp:presented_by acute respiratory illness
systemic symptoms
gptkbp:research_focus vaccine development
antiviral resistance
gptkbp:risk_factor elderly
pregnant women
young children
immunocompromised individuals
chronic disease patients
gptkbp:seasonal_activities winter months
gptkbp:seed_dispersal segmented RNA
gptkbp:social_responsibility gptkb:Person
PCR
induces immune response
rapid antigen test
causes cell death
infects epithelial cells
gptkbp:symptoms muscle pain
cough
fever
sore throat
gptkbp:transmission airborne
respiratory droplets
surface contact
gptkbp:treatment gptkb:baloxavir
gptkb:oseltamivir
gptkb:peramivir
gptkb:zanamivir
gptkb:drug
early treatment preferred
gptkbp:varieties gptkb:Hokage
gptkb:B/_Victoria
gptkbp:bfsParent gptkb:H1_N1_influenza_virus
gptkbp:bfsLayer 5